Alimera Sciences to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

Rhea-AI Summary

Alimera Sciences (Nasdaq: ALIM), a global pharmaceutical firm focused on retinal health, announced that CEO Rick Eiswirth will present at the HC Wainwright 2nd Annual Ophthalmology Conference on August 17, 2022. The presentation will be available on demand starting at 7:00 AM ET. Additionally, Alimera's management will hold one-on-one meetings with registered investors during the conference. This engagement highlights Alimera's commitment to enhancing vision care and its ongoing relationship with the investment community.

ATLANTA, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announced today that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will deliver a corporate presentation at the HC Wainwright 2^nd Annual Ophthalmology Conference being held virtually on Wednesday, August 17, 2022.

The presentation will be available on demand at 7:00am ET on August 17, 2022. In addition to the presentation, management will be available for one-on-one meetings with investors who are registered to attend the conference.

Register here: https://hcwevents.com/ophthalmologyconference/

About Alimera Sciences, Inc.

www.alimerasciences.com

Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com

For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com

FAQ

When will Alimera Sciences present at the HC Wainwright 2nd Annual Ophthalmology Conference?

Alimera Sciences will present on August 17, 2022, starting at 7:00 AM ET.

Who is delivering the presentation for Alimera Sciences at the conference?

Rick Eiswirth, the President and CEO of Alimera Sciences, will deliver the presentation.

Will there be any opportunities for investors to meet with Alimera Sciences' management?

Yes, Alimera's management will be available for one-on-one meetings with registered investors.

How can I access the Alimera Sciences presentation?

The presentation will be available on demand at 7:00 AM ET on August 17, 2022.

What is the stock symbol for Alimera Sciences?

The stock symbol for Alimera Sciences is ALIM.